Artificial differences in clostridium difficile infection rates associated with disparity in testing

Mini Kamboj, Jennifer Brite, Anoshe Aslam, Jessica Kennington, N. Esther Babady, David Calfee, Yoko Furuya, Donald Chen, Michael Augenbraun, Belinda Ostrowsky, Gopi Patel, Monica Mircescu, Vivek Kak, Roman Tuma, Teresa A. Karre, Deborah A. Fry, Yola P. Duhaney, Amber Moyer, Denise Mitchell, Sherry CantuCandace Hsieh, Nancy Warren, Stacy Martin, Jill Willson, Jeanne Dickman, Julie Knight, Kim Delahanty, Annemarie Flood, Jennifer Harrington, Deborah Korenstein, Janet Eagan, Kent Sepkowitz

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

In 2015, Clostridium difficile testing rates among 30 US community, multispecialty, and cancer hospitals were 14.0, 16.3, and 33.9/1,000 patient-days, respectively. Pooled hospital onset rates were 0.56, 0.84, and 1.57/1,000 patient-days, respectively. Higher testing rates may artificially inflate reported rates of C. difficile infection. C. difficile surveillance should consider testing frequency.

Original languageEnglish
Pages (from-to)584-587
Number of pages4
JournalEmerging Infectious Diseases
Volume24
Issue number3
DOIs
StatePublished - Mar 2018

Fingerprint

Dive into the research topics of 'Artificial differences in clostridium difficile infection rates associated with disparity in testing'. Together they form a unique fingerprint.

Cite this